|
References
1. Albrink MJ. Chorionic gonadotropin and obesity?. Am J Clin Nutr 1969
Jun;22(6):681-5
2. Ascheim S; Zondek B. Die Shwangerschafts Diagnose aus dem Harn dureh naehweis
der Hypophysovorderlappenhormone. Klin. Wochschr. 7:1401-1411. 1928
3. Asher WL. Harper HW. Effect of human chorionic gonadotrophin on weight loss.
hunger. and feeling of well-being. Am J Clin Nutr 1973 Feb;26(2):211-8
4. Astrup A. VLCD compliance and lean body mass. Int J Obes 1989;13 Suppl
2:27-31
5. Atkinson JII. et al. Plasma measures of beta-endorphin/betalipotropin-like
immunoreactivity in chronic pain syndrome and psychiatric subjects. Psychiatry
Res. 1983 Aug;9(4):319-27
6. Bagshawe KD. et al. Pregnancy betal glycoprotein and chorionic gonadotrophin
in the serum of patients with trophoblastic and non-trophoblastic tumors. Eur J
Cancer. 1978 Dec;14(12):1331-5
7. Balducci R. et al. Effect of hCG or hCG+ treatments in young thalassemic
patients with hypogonadotropic hypogonadism. J Endocrinol Invest. 1990
Jan;13(1):1-7
8. Bailin JC. White PL. Fallacy and hazard. Human chorionic
gonadotropin-500-calorie diet and weight reduction. JAMA 1974 Nov 4;230(5):693-4
9. Bastow M.D. Anthropometrics revisited. Proc Nutr Soc 1982 Sep;41(3):381-8
10. Berry JN. Use of skinfold thickness for estimation of body fat. Indian J Med
Res 1974 Feb;62(2):233-9
11. Birken S. et al. Isolation and amino acid sequence of COOH-terminal
fragments from the beta subunit of human choriogonadotropin. J Biol Chem. 1977
Aug 10;252(15):5386-92
12. Birken S. Chemistry of human choriogonadotropin. Ann Endocrinol (Paris).
1984;45(4-5):297-305
13. Birmingham CL. et al. Human chorionic
gonadotropin is of no value in the management of obesity. Can Med Assoc J. 1983
May 15;128(10):1156-7
14. Bonandrini L. et al. Chorionie gonadotropin (hCG) in the therapy of chronic
peripheral obliterating arteriopathy (CPOA) of the lower extremities caused by
arteriosclerosis. Minerva Chir. 1970 Mar 15;25(5) :368-83
15. Borkan GA et al. Comparison of ultrasound and skinfold measurements in
assessment of subcutaneous and total fatness. Am J Phys Anthropol 1982
Jul;58(3):307-13
16. Borkan GA, Hults DE, Gcrzof SG, Burrows BA, Robbins AII.Relationships
between computed tomography tissue areas, thicknesses and total body
composition. Ann Hum Biol. 1983 Nov-Dec;10 (6):537-45.
17. Bosch B. et al. Human chorionic gonadotrophin and weight loss.. A
double-blind. placebo-controlled trial. S Afr Med J 1990 Feb 17;77 (4):185-9
18. Bousfield GR. et al. Structural features of mammalian gonadotropins. Mol
Cell Endoerinol. 1996 Dec 20;125(1-2):3-19
19. Bozzola M. et al. Effect of human ehorionic gonadotropin on growth velocity
and biological growth parameters in adolescents with thalassemia major. Eur J
Pediatr. 1989 Jan;148(4):300-3
20. Bradley P Human chorionic gonadotrophin [letter]. Med J Aust Sep
25;2(13):510-1 1976
21. Brambilla. F. et al. beta-Endorphin and beta-lipotropin plasma levels in
chronic schizophrenia. primary affective disorders and secondary affective
disorders. Psychoneuroendocrinology. 1981 Dec;6(4):321-30
22. Bujanow W. Hormones in the treatment of psychoses. Br Med J Nov 4;4(835):298
1972
23. Bujanow W.Letter: Is oxytocin an anti-schizophrenic hormone? Can Psychiatr
Assoc J. 1974 Jun;19(3):323. No abstract available.
24. Cairella M. Drug therapy of obesity. Clin Ter. 1978 Mar 31;84 (6):571-92
25. Canfield RE. et al. Studies of human chorionic gonadotropin. Recent Prog
Horm Res. 1971;27:121-64
26. Cole LA. Immunoassay of human chorionic gonadotropin. Its free.
27. Emrich HM. Endorphins in psychiatry.
Psychiatr Dev 1984 Summer; 2(2):97-114
28. Ferrari C. Use of a testosterone-gonadotropin combination in the treatment
of pathological syndromes in adult males. Minerva Med. 1972 Jun
2;63(42):2399-408
29. Fiddes ,IC. et al. Structure. expression. and evolution of the genes for the
human glycoprotein hormones. Recent Prog Ilorm Res. 1984;40:43-78
30. Fiddes JC. et al. The gene encoding the common alpha subunit of the four
human glycoprotein hormones. J Mol Appl Genet. 1981;1(1):3-18
31. Fleigelman R. Metabolic effects of human ehorionic gonadotropin (hCG) in
rats. Proc Soc Exp Biol Med 1970 Nov;135(2):317-9
32. Gailani S. et al. Human ehorionic gonadotrophins (hCG) in nontrophoblastic
neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and
digestive neoplasms. Cancer. 1976 Oct;38(4):1684-6
33. Gallo RC. Bryant J. Antitumor effects of hCG in KS. Nat Biotechnol
Mar;16(3):218 1998
34. Giudice LC. et al. Glycoprotein hormones: some aspects of studies of
secondary and tertiary structure. Monograph. 1979 May 23
35. Greenway FL. et al. Human ehorionic gonadotropin (hCG) in the treatment of
obesity: a critical assessment of the Simeons method. West J Med 1977
Dec;127(6):461-3
36. Grzonkowski S. Analysis of the results of the measurements of adipose tissue
in the human body based on the study of skinfold thickness. Przegl Epidemiol
1989;43(3):272-82
37. Gusman HA. Chorionie gonadotropin in obesity. Further clinical observations.
Am J Clin Nutr 1969 Jun;22(6):686-95
38. Hashimoto TK. Chorionic gonadotropin preparation as an analgesic. Arch
Intern Med 1981 Feb;141(2):269
39. Hayes PA. Sub-cutaneous fat thickness measured by magnetic resonance
imaging, ultrasound, and calipers. Med Sci Sports Exere 1988 Jun;20(3):303-9
40. Weiss LW, Clark FC.Three protocols for measuring subcutaneous fat thickness
on the upper extremities.Eur J Appl Physiol. 1987;
41. Heitmann BL et al. Evaluation of body fat
estimated from body mass index, skinfolds and impedance. A comparative study.
Eur J Clin Nutr 1990 Nov;44(11):831-7
42. Hermans P. Clumeck N. Picard 0. et al. AIDS-related Kaposi's sarcoma
patients with visceral manifestations. Response to human chorionic gonadotropin
preparations. J Hum Virol Jan-Feb; 1(2): 82-9. 1998
43. LaPorte DJ. Predicting attrition and adherence to a very low caloric diet: a
prospective investigation of the eating inventory. Int J Obes 1990
Mar;14(3):197-206
44. LaPorte DJ. Treatment response in obese binge eaters: preliminary results
using a very low calorie diet (VLCD) and behavior therapy. Addict Behav
1992;17(3):247-57
45. Leshem Y. et al. Gonadotropin promotion of adventitious root production on
cuttings of Begonia semperflorens and Vitis vinifera. Plant Physiol. 1968
Mar;43(3):313-7
46. Lustbader .1W. et al. Structural and molecular studies of human ehorionic
gonadotropin and its receptor. Recent Prog Ilorm Res. 1998;53:395-424
47. Malkin A. The presence of glycosilated, biologically active chorionic
gonadotropin in human liver. Clin Biochem 1985 Apr;18(2):75-7
48. Maruo T. et al. Production of Choriogonadotropin-like factor by a
microorganism. Proc Nat! Acad Sci U S A. 1979 I)ec;76(12):6622-6
49. McGarvey ME. Tulpule A. et al. Emerging treatments for epidemic
(AIDS-related) Kaposi's sarcoma. Curr Opin Oncol Sep;10 (5):413-21 1998
50. Miller R. et al. A clinical study of the use of human chorionic
gonadotrophin in weight reduction. J Fam Pract. 1977 Mar; 4(3):445-8
51. Morgan FJ. et al. Chemistry of human ehorionic gonadotropin. Monograph. 1976
May 25
52. Mueller WII. Relative reliability of circumferences and skinfolds as
measures of body fat distribution. Am .1 Phys Anthropol .1987 Apr;72(4):437-9
53. Niebroj TK. et al. Effect of chorionic gonadotropins administration on water
metabolism in glaucomatous women. Endokrynol Pol. 1971 May-Jun;22(3):251-5
54. Orphanidou C. Accuracy of subcutaneous fat
measurement: comparison of skinfold calipers. ultrasound, and computed
tomography. J Am Diet Assoc 1994 Aug;94(8):855-8
55. Orphanidou CI, McCargar LJ, Birmingham CL, Belzberg AS.Changes in body
composition and fat distribution after short-term weight gain in patients with
anorexia nervosa.Am J Clin Nutr. 1997 Apr ; 65 (4) :1034-41.
56. Perniola R. et. al. Human chorionic gonadotrophin therapy in hypogonadal
thalassaemic patients with osteopenia: increase in bone mineral density. J
Pediatr Endocrinol Metab. 1998;11 Suppl 3:995-6
57. Pickar D et al. Clinical studies of the endogenous opioid system. Biol
Psychiatry 1982 Nov; 17(11): 1243-76
58. Pierce JG. Eli Lilly lecture. The subunits of pituitary thyrotropintheir
relationship to other glycoproteic hormones. Endocrinology. 1971
Dec;89(6):1331-44
59. Rabe T. et al. Risk-benefit analysis of a hCG-500 kcal reducing diet (cura
romana) in females. Geburtshilfe Frauenheilkd. 1987 May; 47(5):297-307
60. Reiss M. Stunted growth and the mechanism of its stimulation in mentally
disturbed adolescents. Int J Neuropsychiatry. 1965 Aug;1 (4):313-7
61. Rivlin RS. Therapy of obesity with hormones. N Engl J. Med. 1975 Jan
2;292(1):26-9
62. Ross GT. Clinical relevance of research on the structure of human chorionic
gonadotropin. Am J Obstet Gynecol. 1977 Dec 1;129 (7): 795-808
63.Sanders S, Norman AP.Chorionic gona.dotrophin in male growth- retarded
adolescent asthmatic patients.Practitioner. 1973 May:210 (259):690-2.
64. Sarma JM. Iloughten RA. Enzyme linked immunosorbent assay (ELISA) for
beta-endorphin and its antibodies. Life Sol 1983;33 Suppl 1:129-32
65. Sarria A et al. Skinfold thickness measurements are better predictors of
body fat percentage than body mass index in male Spanish children and
adolescents. Eur J Clin Nutr 1998 Aug;52(8):573-6
66. Scaffidi A. Data on the pathogenesis and
therapy of bronchial asthma in patients with secondary hypogonadism. Minerva Med
Dec 1;65(86):4473-6 1974
67. Segal S.1 (ed.). Chorionic Gonadotropin. Plenum Press: NY. 1980
68. Shetty KR. et al. IIuman chorionic gonadotropin (hCG) treatment of obesity.
Arch Intern Med. 1977 Feb;137(2):151-5
69. Shomcr-Ilan A. et al. Further evidence for the presence of an endogenous
gonadotrophin-like plant factor: "phytotrophin" .Isolation and mechanism of
action of the active principle. Aust J Biol Sci. 1973 Fcb;26(1):105-12
70. Simeons ATW. The action of chorionic gonadotropin in the obese. Lancet
11:1954: 946-947
71. Simeons ATW. Pounds and Inches: A New Approach to Obesity. Private Printing
(1976)
72. Stein MR. et al. Ineffectiveness of human chorionic gonadotropin in weight
reduction: a double-blind study. Am J Clin Nutr. 1976 Sep;29(9):940-8
73. Stern JS. Weight control programs. Curr Concepts Nutr. 1977; 5:137-55
74. Suginami H. et al. Immunohistochemical localization of a human chorionic
gonadotropin-like substance in the human pituitary gland. J Clin Endocrinol
Metab. 1982 Dec;55(6):1161-6
75. Tagliabue A et al. Application of bioelectrie impedance measurement in the
evaluation of body fat. Recenti Prog Med 1989 Feb;80 (2):59-62
76. Talbot LA et al. Assessing body composition: the skinfold method. AAOHN J
1995 Dec;43(12):605-13
77. Tavio M. Nasti G. Simonelli C. et al. Human chorionic gonadotropin in the
treatment of HIV-related Kaposi's sarcoma. Eur J Cancer Sep;34(10):1634-7 1998
78. Torgerson JS et al. VLCD plus dietary and behavioral support versus support
alone in the treatment of severe obesity. A randomised two-year clinical trial.
Int J Obes Relat Metab Disord 1997 Nov;21(11):987-94
79. Vaitukaitis JL. Glycoprotein hormones and their subunits—immunity
80. Veilleux H. et al. Gonadic and extragonadic
effects in humans of 3.500 I.U. of hCG (human chorionic gonadotropin) in
fractional doses. Vie Med Can Fr. 1972 Sep;1(9):862-71
806.Vogt T, Belluscio D.Controversies in plastic surgery: suction- assisted
lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity
treatment. Aesthetic Plast Surg. 1987;11(3):131-56. Review.
81. Wattanapenpaiboon N. et al. Agreement of skinfold measurement and
bioelectrical impedance analysis (BIA) methods with dual energy X-ray
absorptiometry (DEXA) in estimating total body fat in Anglo-Celtic Australians.
Int J Obes Relat Metab Disord. 1998 Sep;22(9):854-60
82. Weits T. et al. Comparison of ultrasound and skinfold caliper measurement of
subcutaneous fat tissue. hit J Obes 1986;10(3):161-8
83. Yanagihara Y. Carbohydrate and lipid metabolism in pregnant albino rats
during hunger after loading with gonad-stimulating hormones. Nippon Sanka
Fujinka Gakkai Zasshi 1966 Nov;18 (11): 1293-301
84. Ya.nagihara Y. Carbohydrate and fatty acid metabolism in pregnant albino
rats simultaneously loaded with fat emulsion and sex stimulating hormones during
starvation. Nippon Sanka Fujinka Gakkai Zasshi 1967 Jan;19(1):8-14
85. Yanagihara Y. Carbohydrate and lipid metabolism in pregnant albino rats
during starvation after loading with gonad-stimulating hormones. Nippon Sanka
Fujinka Gakkai Zasshi 1966 Dee;18 (12): 1379-84
86. Yoshimoto Y. et al. Human chorionic gonadotropin—like material: presence in
normal human tissues. Am J Obstet Gynecol. 1979 Aug 1;134(7):729-33
87. Yoshimoto Y. et al. Human chorionic gonadotropin-like substance in
nonendocrine tissues of normal subjects. Science. 1977 Aug 5;197(4303):575-7
88. Young RI,. et al. Chorionie gonadotropin in weight control. A double-blind
crossover study. JAMA. 1976 Nov 29;236(22):2495-7
89. Zakut II. et al. hCG as tumor marker in non-trophoblastie neoplasms.
Harefuah. 1985 Jan 15;108(2):82-5
90. Zondek B. Sulman F. The mechanism of action and metabolism of gonadotrophic
hormones in the organism. Vit Florm 1945 3:297-336
About The Author - Kevin Trudeau
Back to
The Weight Loss Cure They Don't Want You To Know About by Kevin Trudeau
Buy
The Weight Loss Cure They Don't Want
You To Know About by Kevin Trudeau
Back To Top
|
